Adam Officer

2.0k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

Adam Officer is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Adam Officer has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Adam Officer's work include Cancer Genomics and Diagnostics (3 papers), Cell Adhesion Molecules Research (3 papers) and Single-cell and spatial transcriptomics (2 papers). Adam Officer is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Cell Adhesion Molecules Research (3 papers) and Single-cell and spatial transcriptomics (2 papers). Adam Officer collaborates with scholars based in United States, Italy and Denmark. Adam Officer's co-authors include Olivier Harismendy, Erick Armingol, Nathan E. Lewis, Jacob D. Jaffe, Patrick Kelly, Yasuhiro Oki, Pierluigi Porcu, Mark Douglas, Raphael Koch and David M. Weinstock and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Nature Reviews Genetics.

In The Last Decade

Adam Officer

14 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deciphering cell–cell interactions and communication from gene expression

2020 742 citations Erick Armingol, Adam Officer et al. Nature Reviews Genetics profile →

Peers

Countries citing papers authored by Adam Officer

Since Specialization

Citations

This map shows the geographic impact of Adam Officer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Officer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Officer more than expected).

Fields of papers citing papers by Adam Officer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Officer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Officer. The network helps show where Adam Officer may publish in the future.

Co-authorship network of co-authors of Adam Officer

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Officer. A scholar is included among the top collaborators of Adam Officer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Officer. Adam Officer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Inhibition of anti-apoptotic BCL2 overcomes adaptive resistance to co-targeting of the protein kinase FAK and MEK in GNAQ-driven uveal melanoma 2025 ·Journal of Biological Chemistry ·Simone Lubrano, Rodolfo Daniel Cervantes‐Villagrana, Nadia Arang, Adam Officer, (unknown), (unknown), Andrew E. Aplin, J. Silvio Gutkind	0
2	FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma 2025 ·Cancer Cell ·Simone Lubrano, Rodolfo Daniel Cervantes‐Villagrana, Farhoud Faraji, Sydney I. Ramirez, Kuniaki Sato, (unknown), Adam Officer, Nadia Arang, Damiano Cosimo Rigiracciolo, (unknown), Claudia Martini, (unknown), Fleur M. Ferguson, Antonietta Bacchiocchi, Ruth Halaban, Sílvia Coma, Sheri L. Holmen, Jonathan A. Pachter, (unknown), J. Silvio Gutkind	11
3	Abstract 4745: A novel combination therapy targeting RAF, MEK and FAK to overcome skin cutaneous melanoma treatment resistance 2024 ·Cancer Research ·Simone Lubrano, Farhoud Faraji, Rodolfo Daniel Cervantes‐Villagrana, Sydney I. Ramirez, Nadia Arang, Adam Officer, Damiano Cosimo Rigiracciolo, (unknown), (unknown), Ruth Halaban, Sílvia Coma, Sheri L. Holmen, Claudia Martini, Jonathan A. Pachter, Andrew E. Aplin, J. Silvio Gutkind	1
4	Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor 2023 ·Journal of Biological Chemistry ·(unknown), Justine S. Paradis, Adam Officer, (unknown), Xingyu Wu, (unknown), Benjamin Barsi‐Rhyne, (unknown), (unknown), (unknown), (unknown), Michel Bouvier, Asuka Inoue, Mark von Zastrow, Carsten Hoffmann, J. Silvio Gutkind	7
5	Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment 2022 ·Cell Reports ·Athanasios Papadas, Gauri Deb, (unknown), Adam Officer, Chelsea Hope, Adam Pagenkopf, (unknown), Zachary Morrow, Philip B. Emmerich, (unknown), (unknown), Varun Bansal, Karla Esbona, Christian M. Capitini, Kristina A. Matkowskyj, Dustin A. Deming, Katerina Politi, Scott I. Abrams, Olivier Harismendy, Fotis Asimakopoulos	21
6	Stem-like breast cancer cells in the activated state resist genetic stress via TGFBI-ZEB1 2022 ·npj Breast Cancer ·Qi Sun, Yu‐Fen Wang, Adam Officer, (unknown), (unknown), Olivier Harismendy, Jay S. Desgrosellier	13
7	The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ 2022 ·npj Breast Cancer ·Daniela Nachmanson, Adam Officer, Hidetoshi Mori, Jonathan Gordon, Mark Evans, (unknown), (unknown), Thomas J. O’Keefe, Farnaz Hasteh, Gary S. Stein, Kristen Jepsen, Donald L. Weaver, Gillian L. Hirst, Brian L. Sprague, Laura J. Esserman, Alexander D. Borowsky, Janet L. Stein, Olivier Harismendy	9
8	Abstract P5-06-02: A gene expression meta-analysis identifies microenvironment differences in cellular composition and cell-cell interactions associated with breast cancer invasion 2022 ·Cancer Research ·Adam Officer, (unknown), Farnaz Hasteh, Michal Slyper, Åsa Segerstolpe, (unknown), Judit Jané‐Valbuena, Orit Rozenblatt‐Rosen, Lyndsay M. Murrow, Zev J. Gartner, Aviv Regev, Christina Yau, (unknown), Olivier Harismendy	1
9	Abstract 131: Remodeling of stromal-epithelial interactions in breast cancer progression as inferred from regional and single-cell gene expression analysis 2021 ·Cancer Research ·Adam Officer, (unknown), Farnaz Hasteh, Michal Slyper, Åsa Segerstolpe, (unknown), Judit Jané‐Valbuena, Orit Rozenblatt–Rosen, Aviv Regev, Christina Yau, Olivier Harismendy	0
10	Avant-garde: an automated data-driven DIA data curation tool 2020 ·Nature Methods ·Alvaro Sebastian Vaca Jácome, Ryan Peckner, Nicholas Shulman, Karsten Krug, Katherine C. DeRuff, Adam Officer, Karen E. Christianson, Brendan MacLean, Michael J. MacCoss, Steven A. Carr, Jacob D. Jaffe	20
11	Mutational profiling of micro-dissected pre-malignant lesions from archived specimens 2020 ·BMC Medical Genomics ·Daniela Nachmanson, (unknown), (unknown), Adam Officer, (unknown), Thomas J. O’Keefe, Farnaz Hasteh, Kristen Jepsen, Gillian L. Hirst, Laura J. Esserman, Alexander D. Borowsky, Olivier Harismendy	4
12	Deciphering cell–cell interactions and communication from gene expression breakdown → 2020 ·Nature Reviews Genetics ·Erick Armingol, Adam Officer, Olivier Harismendy, Nathan E. Lewis	742
13	A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML 2018 ·Blood Advances ·Srila Gopal, Qing Lu, Joshua J. Man, Wendy Baur, (unknown), Lev Litichevskiy, Malvina Papanastasiou, Amanda L. Creech, Katherine C. DeRuff, (unknown), Adam Officer, Shawn B. Egri, Desiree Davison, Jacob D. Jaffe, Iris Z. Jaffe	11
14	Impact of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia on Signaling and Epigenetics in Endothelial Cells 2017 ·Blood ·Srila Gopal, Qing Lu, Wendy Baur, (unknown), Lev Litichevskiy, Malvina Papanastasiou, Amanda L. Creech, Adam Officer, Shawn B. Egri, Desiree Davison, Jacob D. Jaffe, Iris Z. Jaffe	1
15	Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma 2017 ·Blood ·Steven M. Horwitz, Raphael Koch, Pierluigi Porcu, Yasuhiro Oki, Alison J. Moskowitz, Megan N. Perez, Patricia L. Myskowski, Adam Officer, Jacob D. Jaffe, Sara Morrow, Kerstin Allen, Mark Douglas, Howard M. Stern, Jennifer Sweeney, Patrick Kelly, Virginia Kelly, Jon C. Aster, David T. Weaver, Francine M. Foss, David M. Weinstock	204
16	Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes 2016 ·Molecular & Cellular Proteomics ·Jennifer G. Abelin, Jinal Patel, Xiaodong Lü, (unknown), Lọla Fagbami, Amanda L. Creech, (unknown), Daniel D. Lam, Desiree Davison, Lindsay K. Pino, Jana Qiao, Eric Kuhn, Adam Officer, Jianxue Li, Susan E. Abbatiello, Aravind Subramanian, Richard L. Sidman, Evan Snyder, Steven A. Carr, Jacob D. Jaffe	63
17	The Impact of Chemotherapeutic Agents on Signaling and Epigenetics in Vascular Endothelial Cells 2016 ·Blood ·Srila Gopal, Amanda L. Creech, Adam Officer, Shawn B. Egri, Desiree Davison, Jacob D. Jaffe, Iris Z. Jaffe	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact